[1]
|
中华医学会肝病学分会. 肝硬化肝性脑病诊疗指南[J]. 中华内科杂志, 2018, 57(10): 705-718.
https://doi.org/10.3760/cma.j.issn.0578-1426.2018.10.004
|
[2]
|
Lee, H.L. and Lee, S.W. (2022) The Role of Transjugular Intrahepatic Portosystemic Shunt in Patients with Portal Hypertension: Advantages and Pitfalls. Clinical and Molecular Hepatology, 28, 121-134.
https://doi.org/10.3350/cmh.2021.0239
|
[3]
|
Patel, R.K., Chandel, K., Tripathy, T.P. and Mukund, A. (2021) Com-plications of Transjugular Intrahepatic Portosystemic Shunt (TIPS) in the Era of the Stent Graft—What the Intervention-ists Need to Know? European Journal of Radiology, 144, Article ID: 109986. https://doi.org/10.1016/j.ejrad.2021.109986
|
[4]
|
Zuo, L., Lv, Y., Wang, Q., et al. (2019) Early-Recurrent Overt Hepatic Encephalopathy Is Associated with Reduced Survival in Cirrhotic Patients after Transjugular Intrahepatic Porto-systemic Shunt Creation. Journal of Vascular and Interventional Radiology, 30, 148-153.e2. https://doi.org/10.1016/j.jvir.2018.08.023
|
[5]
|
Vilstrup, H., Amodio, P., Bajaj, J., et al. (2014) Hepatic Encephalo-pathy in Chronic Liver Disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver. Hepatology, 60, 715-735. https://doi.org/10.1002/hep.27210
|
[6]
|
Weissenborn, K. (2019) Hepatic Encephalopathy: Definition, Clinical Grading and Diagnostic Principles. Drugs, 79, 5-9. https://doi.org/10.1007/s40265-018-1018-z
|
[7]
|
Wijdicks, E.F. (2016) Hepatic Encephalopathy. The New England Journal of Medicine, 375, 1660-1670.
https://doi.org/10.1056/NEJMra1600561
|
[8]
|
Zeng, X., Yin, C., Sun, C.Y., et al. (2023) Prevalence and Risk Factors of Covert Hepatic Encephalopathy in Cirrhotic Patients: A Multicenter Study in China. Journal of Digestive Dis-eases, 24, 122-132.
https://doi.org/10.1111/1751-2980.13171
|
[9]
|
Mamone, G., Milazzo, M., Di Piazza, A., et al. (2022) Transjugular Intrahepatic Portosystemic Shunt (TIPS) Complications: What Diagnostic Radiologists Should Know. Abdominal Radi-ology (NY), 47, 4254-4270.
https://doi.org/10.1007/s00261-022-03685-0
|
[10]
|
Coronado, W.M., Ju, C., Bullen, J. and Kapoor, B. (2020) Pre-dictors of Occurrence and Risk of Hepatic Encephalopathy after TIPS Creation: A 15-Year Experience. CardioVascular and Interventional Radiology, 43, 1156-1164.
https://doi.org/10.1007/s00270-020-02512-7
|
[11]
|
Lu, K. (2023) Cellular Pathogenesis of Hepatic Encephalopathy: An Update. Biomolecules, 13, Article No. 396.
https://doi.org/10.3390/biom13020396
|
[12]
|
孟书静, 张强, 苏醒, 等. 肝硬化患者发生肝性脑病危险因素的Meta分析[J]. 承德医学院学报, 2022, 39(4): 302-307.
|
[13]
|
Merola, J., Chaudhary, N., Qian, M., et al. (2014) Hy-ponatremia: A Risk Factor for Early Overt Encephalopathy after Transjugular Intra-Hepatic Portosystemic Shunt Crea-tion. Journal of Clinical Medicine, 3, 359-372.
https://doi.org/10.3390/jcm3020359
|
[14]
|
Younas, A., Riaz, J., Chughtai, T., et al. (2021) Hyponatremia and Its Correlation with Hepatic Encephalopathy and Severity of Liver Disease. Cureus, 13, e13175. https://doi.org/10.7759/cureus.13175
|
[15]
|
Guimarães, L., Piedade, J., Duarte, J., et al. (2023) Hepatic Encephalo-pathy in Cirrhotic Patients with Bacterial Infections: Frequency, Clinical Characteristics, and Prognostic Relevance. Journal of Clinical and Experimental Hepatology, 13, 559-567. https://doi.org/10.1016/j.jceh.2023.01.004
|
[16]
|
Bai, Z., Guo, X., Tacke, F., Li, Y., Li, H. and Qi, X. (2019) Asso-ciation of Serum Albumin Level with Incidence and Mortality of Overt Hepatic Encephalopathy in Cirrhosis during Hos-pitalization. Therapeutic Advances in Gastroenterology, 12, 1-14. https://doi.org/10.1177/1756284819881302
|
[17]
|
陈丽娜, 潘陈为, 刘敏欧, 等. 肝硬化患者肝性脑病风险评估量表模型构建与预测价值研究[J]. 中国现代医生, 2023, 61(18): 29-32+73.
|
[18]
|
唐艳芳, 刘旭东, 王文鑫, 等. 肝硬化合并轻微型肝性脑病的临床特点以及相关影响因素分析[J]. 传染病信息, 2022, 35(4): 316-320.
|
[19]
|
申权, 郑晖, 杨维竹, 等. TIPS术后门脉显影和肝脏体积对肝功能及并发肝性脑病的影响[J]. 中华介入放射学电子杂志, 2020, 8(1): 15-18.
|
[20]
|
Liu, J., Zhou, C., Wang, Y., et al. (2021) The Combination of Child-Pugh Score and Quantitative CT-Based Spleen Volume Could Predict the Risk of Hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt Creation. Abdominal Radiology (NY), 46, 3464-3470. https://doi.org/10.1007/s00261-021-02972-6
|
[21]
|
Ruf, A., Dirchwolf, M. and Freeman, R.B. (2022) From Child-Pugh to MELD Score and Beyond: Taking a Walk down Memory Lane. Annals of Hepatology, 27, Article ID: 100535. https://doi.org/10.1016/j.aohep.2021.100535
|
[22]
|
熊峰. 不同肝功能评分模型对TIPS术后显性肝性脑病的预测价值[D]: [硕士学位论文]. 昆明: 昆明医科大学, 2022.
|
[23]
|
Krishnan, A., Woreta, T.A., Vaidya, D., et al. (2023) MELD or MELD-Na as a Predictive Model for Mortality Following Transjugular Intrahepatic Portosystemic Shunt Placement. Journal of Clinical and Translational Hepatology, 11, 38-44.
|
[24]
|
Nardelli, S., et al. (2019) Muscle Alterations Are Associated with Minimal and Overt Hepatic Encephalopathy in Patients with Liver Cir-rhosis. Hepatology, 70, 1704-1713. https://doi.org/10.1002/hep.30692
|
[25]
|
Bhanji, R.A., Moctezuma-Velazquez, C., Duarte-Rojo, A., et al. (2018) Myosteatosis and Sarcopenia Are Associated with Hepatic Encephalopathy in Patients with Cirrhosis. Hepatology International, 12, 377-386.
https://doi.org/10.1007/s12072-018-9875-9
|
[26]
|
Yang, C., Zhu, X., Liu, J., et al. (2022) Development and Valida-tion of Prognostic Models to Estimate the Risk of Overt Hepatic Encephalopathy after TIPS Creation: A Multicenter Study. Clinical and Translational Gastroenterology, 13, e00461. https://doi.org/10.14309/ctg.0000000000000461
|
[27]
|
Dasarathy, S. and Merli, M. (2016) Sarcopenia from Mecha-nism to Diagnosis and Treatment in Liver Disease. Journal of Hepatology, 65, 1232-1244. https://doi.org/10.1016/j.jhep.2016.07.040
|
[28]
|
Bhatia Kapoor, P., Benjamin, J., Tripathi, H., et al. (2023) Post-Transjugular Intrahepatic Portosystemic Shunt Hepatic Encephalopathy: Sarcopenia Adds Insult to Injury. Turkish Journal of Gastroenterology, 34, 406-412.
https://doi.org/10.5152/tjg.2023.21964
|
[29]
|
Wijarnpreecha, K., Werlang, M., Panjawatanan, P., et al. (2020) Asso-ciation between Sarcopenia and Hepatic Encephalopathy: A Systematic Review and Meta-Analysis. Annals of Hepatolo-gy, 19, 245-250.
https://doi.org/10.1016/j.aohep.2019.06.007
|
[30]
|
Ma, Y.J., Cao, Z.X., Li, Y. and Feng, S.Y. (2019) Proton Pump Inhibitor Use Increases Hepatic Encephalopathy Risk: A Systematic Review and Meta-Analysis. World Journal of Gas-troenterology, 25, 2675-2682.
https://doi.org/10.3748/wjg.v25.i21.2675
|
[31]
|
Dai, R., Sag, A.A., Martin, J.G., et al. (2021) Proton Pump Inhibitor Use Is Associated with Increased Rates of Post-TIPS Hepatic Encephalopathy: Replication in an Independent Patient Cohort. Clinical Imaging, 77, 187-192.
https://doi.org/10.1016/j.clinimag.2021.04.034
|
[32]
|
Gairing, S.J., Schleicher, E.M. and Labenz, C. (2023) Diabetes Mellitus-Risk Factor and Potential Future Target for Hepatic Encephalopathy in Patients with Liver Cirrhosis? Metabolic Brain Disease, 38, 1691-1700.
https://doi.org/10.1007/s11011-022-01068-4
|
[33]
|
Labenz, C., Nagel, M., Kremer, W.M., et al. (2020) Association between Diabetes Mellitus and Hepatic Encephalopathy in Patients with Cirrhosis. Alimentary Pharmacology & Thera-peutics, 52, 527-536.
https://doi.org/10.1111/apt.15915
|
[34]
|
Li, X., Partovi, S., Coronado, W.M., et al. (2022) Hepatic Encephalopathy after TIPS Placement: Predictive Factors, Prevention Strategies, and Management. CardioVascular and Interventional Radiology, 45, 570-577.
https://doi.org/10.1007/s00270-021-03045-3
|
[35]
|
Lewis, D.S., Lee, T.-H., Konanur, M., et al. (2019) Proton Pump Inhibitor Use Is Associated with an Increased Frequency of New or Worsening Hepatic Encephalopathy after Transjugu-lar Intrahepatic Portosystemic Shunt Creation. Journal of Vascular and Interventional Radiology, 30, 163-169. https://doi.org/10.1016/j.jvir.2018.10.015
|
[36]
|
张浩, 潘佳佳, 蒋晓芬, 等. 门静脉压力梯度预测TIPS后高危人群肝性脑病的研究[J]. 中华肝脏病杂志, 2021, 29(1): 72-74.
|
[37]
|
Miraglia, R., Maruzzelli, L., Di Piazza, A., et al. (2019) Transjugular Intrahepatic Portosystemic Shunt Using the New Gore Viatorr Controlled Expansion Endoprosthe-sis: Prospective, Single-Center Preliminary Experience. CardioVascular and Interventional Radiology, 42, 78-86. https://doi.org/10.1007/s00270-018-2040-y
|
[38]
|
Srinivasa, R.N., Srinivasa, R.N., Chick, J., Hage, A. and Saad, W.A. (2018) Transjugular Intrahepatic Portosystemic Shunt Reduction Using the Gore Viatorr Controlled Expansion Endoprosthesis: Hemo-Dynamics of Reducing an Established 10-mm TIPS to 8-mm Indiameter. CardioVascular and Interventional Radiology, 41, 518-521.
https://doi.org/10.1007/s00270-017-1807-x
|
[39]
|
Yao, X., He, S., Wei, M. and Qin, J.P. (2022) Influence of Dif-ferent Portal Vein Branches on Hepatic Encephalopathy during Intrahepatic Portal Shunt via Jugular Vein. World Journal of Gastroenterology, 28, 4467-4470.
https://doi.org/10.3748/wjg.v28.i31.4467
|
[40]
|
Ma, J., Luo, J., Zhang, W., et al. (2023) The Influence of Shunting Left/Right Portal Vein Branch on Post-TIPS Hepatic Encephalopathy: A Study Protocol for Multicenter Randomized Blinded Controlled Trial. Trials, 24, Article No. 312. https://doi.org/10.1186/s13063-023-07326-9
|
[41]
|
Luo, S.H., Chu, J.G., Huang, H., Zhao, G.R. and Yao, K.C. (2019) Targeted Puncture of Left Branch of Intrahepatic Portal Vein in Transjugular Intrahepatic Portosystemic Shunt to Reduce Hepatic Encephalopathy. World Journal of Gastroenterology, 25, 1088-1099. https://doi.org/10.3748/wjg.v25.i9.1088
|
[42]
|
Zuo, K., Wang, C., Wang, J., Xia, F.F. and Song, T. (2021) Transjugular Intrahepatic Portosystemic Shunt through Left Branch versus Right Branch of Portal Vein: A Me-ta-Analysis. Abdominal Radiology (NY), 46, 1718-1725.
https://doi.org/10.1007/s00261-020-02789-9
|
[43]
|
Yang, C., Chen, Y., Wang, C., et al. (2022) Portal Flow Diver-sion Based on Portography Is Superior than Puncture Site in the Prediction of Overt Hepatic Encephalopathy after TIPS Creation. BMC Gastroenterology, 22, Article No. 363. https://doi.org/10.1186/s12876-022-02447-y
|
[44]
|
Trebicka, J., Bastgen, D., Byrtus, J., Praktiknjo, M., Terstiegen, S., Meyer, C., et al. (2019) Smaller-Diameter Covered Transjugu-lar Intrahepatic Porto-Systemic Shunt Stents Are Associated with Increased Survival. Clinical Gastroenterology and Hepatology, 17, 2793-2799.e1. https://doi.org/10.1016/j.cgh.2019.03.042
|
[45]
|
Liu, J., Ma, J., Zhou, C., et al. (2021) Potential Benefits of Underdilation of 8-mm Covered Stent in Transjugular Intrahepatic Portosystemic Shunt Cre-ation. Clinical and Translational Gastroenterology, 12, e00376.
https://doi.org/10.14309/ctg.0000000000000376
|
[46]
|
Li, W., Duan, Y., Liu, Z., et al. (2022) Clinical Value of Hemodynamic Changes in Diagnosis of Hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt. Scandinavian Journal of Gastroenterology, 1-6.
https://doi.org/10.1080/00365521.2022.2029938
|
[47]
|
Wang, J.F., Ma, J.Q., Luo, J.J., et al. (2020) Hemodynamic Response in Cirrhotic Patients with Transjugular Intrahepatic Portosystemic Shunt. Chinese Journal of Internal Medicine, 59, 700-705.
|
[48]
|
陈兵勇, 陈婕, 李景珊, 等. 二维斑点追踪成像评价肝硬化失代偿期患者心室功能的价值[J]. 岭南心血管病杂志, 2021, 27(1): 85-90.
|